Maximum Retail Prices of Medicines
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
The Medical Devices Regulatory Division of the NMRA has revised the Consolidated Dossier Submission Checklist for New Product Registration (F-MDR-035). The revised format can be obtained from the “Application Forms” tab under the Medical Devices Regulatory Division on the NMRA website.
Accordingly,all Market Authorization Holders are advised to submit consolidated dossiers in compliance with the revised checklist with effect from 02nd June 2026.
Chief Executive Officer
National medicines Regulatory Authority
Notice to all Authorized Local Agents
Subject: Average US Dollar Rate May-2026 for Price Approvals of MRP’s by NMRA
This is to kindly inform all authorized local agents that the USD rate considered for the month of May-2026 for processing price details of medicines/medical devices is 315.19
Please ensure that all price submissions for MRP approvals are prepared accordingly.
The Pharmacies regulatory divisions of National medicines regulatory authority has introduced an online application portal for all pharmacy licenses related applications. With effect from today (21/04/2026), all applications for retail pharmacy and wholesale establishment will be accepted only through this online portal.
The link to access the portal is available on the NMRA official website under the pharmacy regulatory division. Details instructions for application submission also are provided on the portal.
All applicants are kindly requested to submit their applications accordingly.
Renewal applications will be considered if the existing license has expired within two years from the date of submission of the application to NMRA with penalty and appropriate fee for the period.
Renewal applications submitted after two years from the date of expiry of the existing license will be considered as a new application. Existing rules and regulations for a new pharmacy will be applicable.
The above provisions will be applicable only up to 31 December 2026.
Click Here : Renewal of Expired Pharmacy Licenses
The National Medicines Regulatory Authority (NMRA) requires all local manufacturers to submit comprehensive production and supply chain data for the calendar years2023, 2024, and 2025.Please refer the attachment.
Submission Method: Please email your data to mc@nmra.gov.lk.
Format: Submissions must be in a digital format(Excel preferred) to ensure accuracy.
For any technical clarifications or inquiries, please contact the Market Surveillance and Control Division through mc@nmra.gov.lk
